INTRODUCTION
SITE SEARCH
BPSi Clinical Mental Model
ASSESSMENT
PAIN EKG
>
PAIN EKG - P
>
Predisposition
Precipitation
Pattern
Provocation
Prior Treatments
Palliative
Patient Beliefs
PAIN EKG - Q
>
Quality of Pain
Quality of Life
PAIN EKG - R
>
Region of Pain
Reflexes Affected
Red Flags
Risk Assessment
PAIN EKG - S
>
Severity of Pain
Sensory Abnormalities
Strength Abnormalities
Sanity Issues
PAIN EKG - T
>
Timing of Pain
Testing for Cause
Tolerance for Pain
INTERPRETATION
>
Nociceptive/Peripheral
Neuropathic
Centralized
Complexity
COMMON CONDITIONS
Back Pain Pointers
>
Back Pain Differential
Facet Joint Disease
Radiculopathy
Treatment for Low Back Pain
Do Not Do for Acute LBP
Fibromyalgia Syndrome
>
FMS Signs & Symptoms
FMS Diagnosis
FMS Drug Treatment
FMS Non-Drug Treatment
TREATMENT IN GENERAL
VA-DoD OPIOID 2022 CPG
Module A
Module B
Module C
DRUG TREATMENT
WHO Pain Ladder
Non-Opioids
>
Antidepressants
Anticonvulsants
Miscellaneous
Opioids - General Info
>
General Pointers
Opioid Tx Protocol
Managing Side Effects
Opioid Conversion
Drug Rotation
Common Opioids
Opioid Complications
Tapering Opioids
NALOXONE RESCUE
MONITORING TREATMENT
5 A's
Urine Drug Testing
>
UDT General Pointers
Specific UDT Examples - A
Specific UDT Examples - B
Validating Urine Samples
Monitoring Agreement Issues
State PDMP Links
>
Ohio (pmpaware) Link
Pennsylvania (pmpaware) Link
West Virginia PDMP
TIME TO REFER
LEXICON
Addiction
Substance Use Disorder
Pseudoaddiction
Physical Dependence
Tolerance
Hyperalgesia
Drug Diversion
PAIN & THE MIND
PROVIDER RESOURCES
ADDICTION RESOURCES
PATIENT RESOURCES
USEFUL WEB LINKS
FEEDBACK
DRUG TREATMENT
- Common
Opioids -
Fentanyl
Long-acting: Transdermal fentanyl (Duragesic patch)
Dosing
: 12-25 µg/h patch q 72 h (avoid in opioid-naïve patients)
Peak effects occur 12-24 hours after application and effects last 12-24 hours after removal of patch
Use product specific information for dose conversion from prior opioid
Use 50% of the dose in mild or moderate hepatic or renal impairment, avoid use in severe hepatic or renal impairment
Application & Handling
Apply to intact/non-irritated/non-irradiated skin on a flat surface.
Skin may be prepped by clipping hair, washing site with water only
Rotate site of application.
Do not cut.
Avoid exposure to heat.
Avoid accidental contact when holding or caring for children.
Dispose of used/unused patches by folding the adhesive side together and flushing down the toilet.
Specific contraindications:
Management of acute or intermittent pain, or in patients who require opioid analgesia for a short period of time.
Management of post-operative pain, including use after outpatient or day surgery.
Management of mild pain
BACK
DailyMed